95310 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
KIF18A INHIBITORS
#2DYNAMIN ACTIVATORS
#3Substituted Bicyclic Heteroaryl Sulfonamide Derivatives for the Treatment of Cancer
#4CRYPTOPHYCIN COMPOUNDS AND CONJUGATES THEREOF
#5NON-ACID INHIBITORS OF INOSITOL HEXAKISPHOSPHATE KINASE (IP6K) AND METHODS OF USE THEREOF
#6BENZOTRIAZOLE COMPOUND
#7SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF
#8NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
#9HETEROCYCLIC INHIBITORS OF GLUT9 FOR TREATMENT OF DISEASE
#10THIADIAZOLE-SUBSTITUTED COMPOUND, PHARMACEUTICAL COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF
#11ANTI-BIOFILM COMPOUNDS
#12HYBRID PHARMACEUTICAL COMPOSITION OBTAINED BY CONJUGATION OF A PROTON PUMP INHIBITOR AND A CARBON ANHYDRASE INHIBITOR
#13BENZOTRIAZOLE COMPOUND
#14ETHER LINKED TRIAZOLES AS NRF2 ACTIVATORS
#15KIF18A INHIBITORS
#16INHIBITORS OF MYELOPEROXIDASE
#17MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#18NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME
#19MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES
#20BENZIMIDAZOLE DERIVATIVES, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
#21COMPOUNDS WITH IMMUNOMODULATORY ACTIVITY AND THERAPEUTIC USES THEREOF
#22MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO
#23NRF2-ACTIVATING COMPOUND
#24SMALL MOLECULE DEGRADERS OF HELIOS AND METODS OF USE
#25ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME
#26KIF18A inhibitors
#27Ether linked triazoles as NRF2 activators
#28DEGRADERS THAT TARGET PROTEINS VIA KEAP1
#29Compound for organic electric element, organic electric element using the same, and electronic device thereof
#30Pyrimidine TBK/IKKe inhibitor compounds and uses thereof
#31Anti-biofilm compounds
#32RADIOLABELLED mGluR2 PET LIGANDS
#33Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
#34Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
#35HYDROXYISOXAZOLINES AND DERIVATIVES THEREOF
#36Compound for inhibiting nicotinamide phosphoribosyltransferase and composition containing same
#37KIF18A inhibitors
#38COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
#39Ether linked triazoles as NRF2 activators
#40N-ARYL PYRAZOLES AS NRF2 REGULATORS
#41Aryl hydrocarbon receptor modulators
#42Solid forms comprising 4-amino-2-(2,6- dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
#43NRF2 Regulators
#44Compositions and methods for inhibition of the JAK pathway
#45Radiolabelled mGluR2 PET ligands
#46Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
#47Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
#48Heteroarylpiperidine and -piperazine derivatives as fungicides
#49Heterocyclic derivative having AMPK-activating activity
#50Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine
#51FORMULATIONS CONTAINING TIOTROPIUM, AMINO ACID AND ACID AND METHODS THEREOF
#52Solid forms comprising 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione and a coformer, compositions and methods of use thereof
#53Quinolone derivatives as antibacterials
#54Compositions and methods for inhibition of the JAK pathway
#55Pyrrolo[2,1-F[1,2,4]triazine compounds, preparation methods and applications thereof
#56Benzimidazole derivatives as RLK and ITK inhibitors
#57Pyrimidine compounds containing seven-membered fused ring systems
#58Nrf2 regulators
#59N-acylimino heterocyclic compounds
#60Compositions and methods for inhibition of the JAK pathway
#61Heteroarylpiperidine and piperazine derivatives as fungicides
#62SUBSTITUTED PYRIMIDINES FOR THE TREATMENT OF DISEASES SUCH AS CANCER
#63Compositions and methods for inhibition of the JAK pathway
#64Substituted aryloxazoles and their use
#65Tyrosine kinase inhibitors containing a zinc binding moiety
#66TRPV4 antagonists
#67Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
#68Compositions and methods for inhibition of the JAK pathway
#69Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
#70Compositions and methods for inhibition of the JAK pathway
#711,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#72Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
#73Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine
#74Compositions and methods for inhibition of the JAK pathway
#75Compositions and methods for inhibition of the JAK pathway
#76Compositions and methods for inhibition of the JAK pathway
#77Compositions and methods for inhibition of the JAK pathway
#78Compositions and methods for inhibition of the JAK pathway
#79Substituted pyrimidines for the treatment of diseases such as cancer
#80Compounds and methods for the treatment or prevention of infections
#81Tyrosine kinase inhibitors containing a zinc binding moiety
#82PYRROLINONE COMPOUNDS AS INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF
#83Substituted aryloxazoles and their use
#841,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#85Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine
#86Heteroaryls and uses thereof
#87ORGANIC COMPOUNDS AND THEIR USES
#88Compositions and methods for inhibition of the JAK pathway
#89Substituted pyrrolidine amides, the production thereof, and the use thereof as medications
#90HETEROCYCLIC INHIBITORS OF BACTERIAL PEPTIDYL TRNA HYDROLASE AND USES THEREOF
#91Substituted Pyrazalones
#92PYRIMIDINE DERIVATIVES FOR THE INHIBITION OF IGF-IR TYROSINE KINASE ACTIVITY
#93Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
#94Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity
#95Amido Anti-viral Compounds
#96Chemical compounds
#97Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide-derivatives as factor Xa inhibitors
#98Tyrosine kinase inhibitors containing a zinc binding moiety
#99Substituted isoxazoles as fungicides
#100SUBSTITUTED QUINAZOLIN-4-YLAMINE ANALOGUES
#101Heterocyclic compounds
#102Formulations and methods of administration of cephalotaxines, including homoharringtonine
#1031,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
#104Substituted quinazolin-4-ylamine analogues
#105Compounds and methods for the treatment or prevention of infections
#106Substituted pyrrolidinones, their manufacture and their use as medicaments